The global rapid influenza diagnostics market is anticipated to grow on account of growing prevalence of influenza coupled with rising awareness across the developed and emerging economies. In the near future, an increase in influenza awareness, especially in developed regions, would fuel global market growth. The growth of the industry will be boosted by expanded healthcare investment based on R&D for influenza detection and therapeutics. The growth of the global rapid influenza diagnostics market will be boosted by increasing awareness towards rapid influenza diagnostic tests due to several benefits, such as disease specificity & quick findings. However, the lack of trained healthcare practitioners along with many influenza virus-related mutations will hinder the market development of rapid influenza diagnostic tests over the projected timeframe.

The global rapid influenza diagnostics market is categorized based on product, and end-use. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to growing government initiatives to tackle the outbreak of influenza. Factors that are catapulting demand growth are supposed to be the introduction of digital technologies and growing recognition among people. Asian countries are strongly engaged in taking protective steps to tackle the outbreak of the disease and there is raising concern. All these factors are projected to fuel demand for rapid influenza diagnostics market across the region

Key segments of the global rapid influenza diagnostics market

Product Overview, 2018-2028 (USD Million)

• RIDT for Influenza A
• RIDT for Influenza B

End-Use Overview, 2018-2028 (USD Million)

• Hospitals
• Diagnostics Centers
• Research Laboratories

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• South America
  • Brazil
  • Mexico
  • Rest of South America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East and Africa

Important Companies in Global Rapid Influenza Diagnostics Market

• DiaSorin Molecular LLC
• BD
• SA Scientific
• Coris BioConcept
• Meridian Bioscience Inc.
• Abbott
• Analytik Jena
• F. Hoffmann-La Roche Ltd
• Quidel Corporation
• Princeton BioMeditech Corporation

Reasons for the study

• The purpose of the study is to give an exhaustive outlook of the global Rapid Influenza Diagnostics industry
• The overall segmentation of Rapid Influenza Diagnostics market, especially key segments are thoroughly studied.
• Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of Rapid Influenza Diagnostics market

What does the report include?

• The study on the global rapid influenza diagnostics market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
• Additionally, the market competition has been evaluated using the Porter’s five forces analysis
• The study covers qualitative and quantitative analysis of the market segmented on the basis of applications, product, technology and end user. Moreover, the study provides similar information for the key geographies.
• Actual market sizes and forecasts have been provided for all the considered segments
• The study includes the profiles of key players in the market with a significant global and/or regional presence

Who should buy this report?

• The report on the global rapid influenza diagnostics market is suitable for all the players across the value chain including raw material suppliers, Rapid Influenza Diagnostics providers, diagnostic kits manufacturers, distributors, suppliers and retailers
• Venture capitalists and investors looking for more information on the future outlook of the global rapid influenza diagnostics market
• Consultants, analysts, researchers, and academicians looking for insights shaping the global rapid influenza diagnostics market